Since it has been described that resveratrol’s anti-oxidant and anti-inflammatory properties are associated with protection in ischemia, we hypothesized that resveratrol treatment should not affect GLUT3 up-regulation induced in astrocytes after cerebral ischemia. Here, SLC2A3 is linked to brain ischemia.